Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer

There is a need to refine the selection of patients with oropharyngeal squamous cell carcinoma (OPSCC) for treatment de-escalation. We investigated whether pretreatment absolute lymphocyte count (ALC) predicted overall survival (OS) benefit from the addition of concurrent chemotherapy to radical rad...

Descripción completa

Detalles Bibliográficos
Autores principales: Price, James M., Mistry, Hitesh B., Betts, Guy, Cheadle, Eleanor J., Dixon, Lynne, Garcez, Kate, Illidge, Tim, Iyizoba-Ebozue, Zsuzsanna, Lee, Lip Wai, McPartlin, Andrew, Prestwich, Robin J.D., Papageorgiou, Savvas, Pritchard, Dylan J., Sykes, Andrew, West, Catharine M., Thomson, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273368/
https://www.ncbi.nlm.nih.gov/pubmed/35385334
http://dx.doi.org/10.1200/JCO.21.01991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273368/
https://www.ncbi.nlm.nih.gov/pubmed/35385334
http://dx.doi.org/10.1200/JCO.21.01991

Ejemplares similares